Identification of Corynebacterium species may be challenging. Corynebacterium species are occasional causes of prosthetic joint infection (PJI), but few data are available on the subject. Based on the literature, C. amycolatum, C. aurimucosum, C. jeikeium, and C. striatum are the most common Corynebacterium species that cause PJI. We designed a rapid PCR assay to detect the most common human Corynebacterium species, with a specific focus on PJI. A polyphosphate kinase gene identified using whole-genome sequence was targeted. The assay differentiates the antibiotic-resistant species C. jeikeium and C. urealyticum from other species in a single assay. The assay was applied to a collection of human Corynebacterium isolates from multiple clinical sources, and clinically relevant species were detected. The assay was then tested on Corynebacterium isolates specifically associated with PJI; all were detected. We also describe the first case of C. simulans PJI.
W
hile Gram-positive aerobic cocci cause most cases of prosthetic joint infection (PJI), Corynebacterium species are occasional causes. Since the publication of the few reports on Corynebacterium PJI, several new Corynebacterium species have been described. The genus now includes over 85 species (http: //old.dsmz.de/microorganisms/bacterial_nomenclature_info .php?genusϭCorynebacterium), not all isolated from humans. As normal human flora, Corynebacterium species are common contaminants in clinical specimens. Because of this, as well as challenges in their identification, they have not received a great deal of attention in clinical practice. They are, however, increasingly recognized as causes of significant human infection, including PJI (1, 16, 20, 22) .
Corynebacterium species commonly isolated in the clinical laboratory include C. amycolatum, C. aurimucosum, C. glucuronolyticum, C. jeikeium, C. pseudodiphtheriticum, C. striatum, C. tuberculostearicum, and C. urealyticum (8) . C. glucuronolyticum and C. urealyticum are involved predominantly in urinary tract infection and C. pseudodiphtheriticum in respiratory tract infection (8) ; the other five commensal flora species (10) are potential causes of device-associated infections, including PJI (13, 19) . Corynebacteria that cause orthopedic device-associated infections are not usually identified to the species level, and specific Corynebacterium species involved in PJI are not definitively known.
As mentioned, many laboratories do not routinely identify Corynebacterium species, because they are frequently isolated as contaminants and their identification is challenging. In our laboratory, the term "small non-spore-forming Gram-positive bacillus resembling Corynebacterium species" is often used for coryneform organisms, since it can be challenging to differentiate Corynebacterium species from Turicella otidis, Arthrobacter species, Brevibacterium species, Dermabacter hominis, Rothia dentocariosa, Exiguobacterium acetylicum, Helcobacillus species, Oerskovia turbata, Cellulomonas species, Cellulosimicrobium species, Microbacterium species, Curtobacterium species, and Leifsonia aquatica using a simplistic strategy (8) . For species-level identification, phenotypic testing such as with API Coryne (bioMérieux, Durham, NC) has been used. Sequencing-based methods targeting the 16S rRNA gene or rpoB give more precise species identification (11) . Of these, rpoB sequencing is ideal but not commonly available; none of these methods is rapid.
As an alternative approach for rapid identification of Corynebacterium species, a PCR assay targeting the Corynebacterium species that most frequently cause human infection, with a specific focus on those causing PJI, was designed. In addition to detection of Corynebacterium species, the assay differentiates the antibioticresistant species C. jeikeium and C. urealyticum from other species. The assay was first tested on a collection of Corynebacterium isolates representing multiple species. It was then tested on isolates specifically associated with PJI, which were also identified using rpoB or 16S rRNA gene sequencing. Finally, we compared our results on the microbial ecology of PJI to the literature on the topic.
MATERIALS AND METHODS

Control isolates.
Nineteen clinical Corynebacterium species characterized by partial rpoB gene sequencing (2) and C. glutamicum ATTC 13032 were studied ( Table 1) . The five specifically targeted clinical species are in bold in Table 1 . In addition, 338 non-Corynebacterium isolates, identified using phenotypic methods or 16S rRNA gene sequencing, from patients with biofilm-associated infections were used to assess cross-reactivity (Table 2) .
Clinical isolates from the site of PJI. Nine Corynebacterium species isolated from the site of hip or knee PJI between 1999 and 2008 were studied. They were characterized by partial rpoB (2) or (if rpoB failed) partial 16S rRNA gene (12) sequencing, and their antimicrobial susceptibilities were determined following current guidelines (4) . DNA extraction. DNA was extracted using the QIAamp DNA Minikit (Qiagen, Valencia, CA).
Real-time PCR assay design. A potential target corresponding to a polyphosphate kinase gene, pvdS2, of C. jeikeium strain K411 (accession number NC_007164) was identified in the genomes of C. aurimucosum ATCC 700975, C. jeikeium K411, and C. urealyticum DSM7109 (14, 15, 18) . A consensus sequence was created using Sequencher (GeneCodes, Ann Arbor, MI) and primers (forward and reverse 1 [ Table 3 ]) designed with Roche LightCycler Primer Design software. Primers (Integrated DNA Technologies, Coralville, IA) were initially evaluated on DNA from control organisms with SYBR green (Roche Applied Science, Indianapolis, IN) detection using the LightCycler 1.0 (Roche Applied Science, Indianapolis, IN). C. jeikeium, C. urealyticum, C. aurimucosum, and C. striatum, but not C. amycolatum or C. tuberculostearicum, were detected. The putative kinase genes of the two nondetected species were amplified with primers Seq Coryne kin F and R (Table 3) and sequenced, as previously described (12) . Based on known and new sequence data, a third primer (reverse 2) was designed to enable the detection of the five clinically relevant PJI species with all three primers combined. Three fluorescence resonance energy transfer (FRET) probes, i.e., a donor probe labeled with fluorophore (fluorescein isothiocyanate [FITC] ) at the 3= end (probe 1) and two acceptor probes, one labeled with the fluorophore LC705 at the 5= end (probe 3, specific for C. jeikeium) and the other with the fluorophore LC640 at the 5= end (probe 2, detects other Corynebacterium species), were incorporated (Table 3 ). Primers and probes (TIB Molbiol, Berlin, Germany) were evaluated with DNA from Corynebacterium species (Table  1) and non-Corynebacterium species (Table 2) .
PCR optimization. Two microliters of template DNA was added to 18 l PCR mix (LightCycler FastStart DNA Master HybProbe mixture; Roche Applied Science) for a 20-l final reaction volume. The cycling parameters initially evaluated were preincubation for 10 min at 95°C followed by 35 cycles of 95°C for 10 s, 55°C for 10 s, and 72°C for 22 s. Melting curve analysis (starting at 45°C) was performed with a temperature transition rate of 0.8°C/s to determine the melting temperature (T m ). The assay was optimized for primer concentration, forward/reverse primer ratio, Mg 2ϩ concentration, annealing temperature, and number of cycles. Parameters giving the lowest crossing point for standardized positive controls were selected.
Optimization of the LightCycler PCR assay. The optimal Mg 2ϩ , probe, and forward primer and reverse primer concentrations were 4 mM, 0.2 M, 0.4 M, and 2.0 M, respectively. The optimal annealing temperature and cycle number were 57°C and 35, respectively. 
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LOD. The limit of detection (LOD) was determined by testing serial 10-fold dilutions of known concentrations of C. tuberculostearicum and C. jeikeium.
RESULTS
Inclusivity and cross-reactivity. All isolates of the five common human PJI species (C. amycolatum, C. aurimucosum, C. jeikeium, C. striatum, and C. tuberculostearicum) were detected ( Table 1) . Nine other species, including C. glucuronolyticum, C. pseudodiphtheriticum, and C. urealyticum, were also detected. Four unusual species (C. accolens, C. durum, Corynebacterium group F1, and C. riegelii) and non-Corynebacterium isolates (Table 2) were not detected.
Limit of detection. The LODs were 200 and 440 CFU/ml for C. tuberculostearicum and C. jeikeium, respectively.
Melting curve analysis. The LC640 probe is detected in channel 1 of the LightCycler (measured using F2/F1 color compensation) and the LC705 probe in channel 2 (measured using F3/F2 color compensation). In the melting curve analysis (Table 1) , most species tested yielded a T m only in channel 1. Characteristic T m values were found for some species (e.g., 64°C for C. amycolatum). C. jeikeium and the closely related C. urealyticum yielded a T m in channel 2 only. Only C. aurimucosum yielded T m values in both channels, but with a T m different from that of C. jeikeium in channel 2, allowing differentiation. C. aurimucosum did not yield a crossing point in channel 2 using quantification curve analysis.
Interpretative criteria. Interpretative criteria were established by assessment of the bacteria shown in Tables 1 and 2 . A T m of Ͼ60°C in only channel 2, in conjunction with a quantification curve, was considered positive for C. jeikeium or the closely related C. urealyticum; the absence of a quantification curve or the presence of a quantification curve and the absence of a corresponding T m of Ͼ60°C was considered negative for C. jeikeium and C. urealyticum. A T m in channel 1, in conjunction with a quantification curve, was considered positive for non-jeikeium/urealyticum Corynebacterium species. Certain species are differentiated by their T m s. The absence of a T m in both channels was considered negative for Corynebacterium species (with the caveat that C. accolens, C. durum, Corynebacterium group F1, and C. riegelii are not detected).
Clinical isolates from the site of PJI. All isolates from the site of clinically defined PJI (5) were detected (Tables 4 and 5 ). IDRL-6128 yielded a T m of Ͼ60°C in channel 2 only and was identified as C. jeikeium by rpoB sequencing. IDRL-8271 yielded a T m in both channels (T m of Ͻ60°C in channel 2) and was identified by partial 16S rRNA gene sequencing as C. aurimucosum (rpoB sequencing failed). The remaining isolates had a T m in channel 1 only. Three (IDRL-6031, -6110, and -6281) had a T m of 64°C and were identified as C. amycolatum, and one (IDRL-7596) had a T m of 55°C and was identified as Corynebacterium propinquum. IDRL-7734 yielded an unexpected T m of 52°C and was identified as Corynebacterium simulans by rpoB sequencing. Finally, IDRL-6330 yielded a T m of 66°C; rpoB sequencing failed, and partial 16S rRNA gene sequencing showed 100% and 99.7% homology with two unnamed Corynebacterium sp. strains, Corynebacterium sp. strain 96447 (6) and Corynebacterium sp. strain 3301750 (11), respectively (Table 5 ). All results were therefore as expected ( Table 1) . Four of the 9 isolates (IDRL-6031, -6128, -6281, and -7734) were isolated from at least two tissue cultures, and these were all monomicrobial infections. For the remaining isolates, whether they were the cause of the PJI with which they were associated is unknown; some may be contaminants (Table 4) . Most isolates were susceptible to the antimicrobial agents tested, with some exceptions. C. amycolatum IDRL-6281 was intermediate to penicillin and resistant to cefazolin, erythromycin, clindamycin, and levofloxacin; C. jeikeium IDRL-6128 was resistant to penicillin and cefazolin and intermediate to levofloxacin (Table 4) .
DISCUSSION
Corynebacterium genus-specific real-time PCR allows more rapid identification than API Coryne or sequencing-based approaches. (19) . Seventy-three coryneform bacteria were identified to the species level; the most frequent species were C. amycolatum, C. striatum, and C. jeikeium. Nine isolates were considered clinically significant as sole agents of PJI (4 C. striatum, 3 C. amycolatum, and 1 each C. jeikeium and Corynebacterium species). At the time, C. aurimucosum and C. tuberculostearicum had not been described (they were described in 2002 [21] and 2004 [7] , respectively). In both studies, C. amycolatum was highlighted as a cause of PJI.
A retrospective analysis of Corynebacterium species isolated at our institution from the site of hip or knee PJI was performed. Nine available isolates were analyzed with the described assay, all were detected, and the sole C. jeikeium isolate was correctly identified. This study confirms Corynebacterium species as causes of PJI. Corynebacterium PJI is rare. Four monomicrobial infection cases were found, which is unusual, with five case reports (1, 16, 20, 22) and the cases in the von Graevenitz study (19) , previously describing this entity. We describe a case of C. jeikeium PJI, which has been previously reported (16) ; as expected, this isolate was resistant to penicillin and cefazolin. Two cases of C. amycolatum PJI are also described; this commensal flora organism has been previously described as a cause of PJI (13, 19) . Finally, we describe one case of C. simulans PJI which, to best of our knowledge, has not been previously described. The isolate was susceptible to penicillin and vancomycin, and the patient's outcome was favorable following two-stage implant exchange and a course of intravenous ertapenem. Overall, C. amycolatum was identified in three cases. We also identified C. propinquum in one case, with the same T m (55°C) as the closely related species C. pseudodiphtheriticum (11) ( Table 1) . C. propinquum and C. pseudodiphtheriticum are commensal flora and/or pathogens of the respiratory tract, especially the oropharynx. Finally, for IDRL-6330, rpoB sequencing failed and 16S rRNA gene sequencing showed 100 and 99.7% homology with two unnamed Corynebacterium sp. strains, Corynebacterium sp. strain 96447 (6) and Corynebacterium sp. strain 3301750 (11) , respectively. This isolate may represent a yet-to-be described species.
This study highlights the need for antimicrobial susceptibility testing on clinically significant Corynebacterium species. C. jeikeium is not the only penicillin-resistant species; furthermore, some C. jeikeium strains lack penicillin resistance (9) .
Human microbiome studies are now frequent in the literature. Gao et al. analyzed superficial skin bacterial biota of the human forearm and found that the Corynebacterium genus was one of the most frequent genera present, with C. tuberculostearicum being the most frequent Corynebacterium species detected (10) .
In conclusion, we designed a Corynebacterium real-time PCR assay which detects Corynebacterium species frequently described in human pathology and specifically in PJI. This assay is rapid and specific and can differentiate C. jeikeium and C. urealyticum, which are usually resistant to multiple antibiotics, from other species. Our analysis of clinical isolates from the site of PJI (all detected by our assay) and review of the literature highlight two points: the need for identification and antimicrobial susceptibility testing of clinically significant Corynebacterium isolates.
